End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.39 CNY | -3.00% | -5.63% | -32.78% |
Apr. 19 | Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | Sailong Pharmaceutical Group Co.,Ltd. Approves Board Elections | CI |
Sales 2022 | 264M 36.48M | Sales 2023 | 311M 42.9M | Capitalization | 2.46B 340M |
---|---|---|---|---|---|
Net income 2022 | -37M -5.11M | Net income 2023 | 9M 1.24M | EV / Sales 2022 | 8.36 x |
Net Debt 2022 | 71.16M 9.83M | Net Debt 2023 | 38.16M 5.27M | EV / Sales 2023 | 8.04 x |
P/E ratio 2022 |
-57.3
x | P/E ratio 2023 |
258
x | Employees | 483 |
Yield 2022 * |
-
| Yield 2023 |
0.14% | Free-Float | 33.91% |
1 day | -3.00% | ||
1 week | -5.63% | ||
Current month | -3.00% | ||
1 month | -7.21% | ||
3 months | -5.72% | ||
6 months | -37.48% | ||
Current year | -32.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chi Nong Cai
CEO | Chief Executive Officer | 51 | 02-04-02 |
Jing Gao
DFI | Director of Finance/CFO | 48 | 13-07-31 |
Jian Feng Li
CTO | Chief Tech/Sci/R&D Officer | 43 | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nan Gui Cai
FOU | Founder | 62 | 02-04-02 |
Chi Nong Cai
CEO | Chief Executive Officer | 51 | 02-04-02 |
Lin Tang
BRD | Director/Board Member | 50 | 04-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-02 | 9.39 | -3.00% | 2 461 540 |
24-05-31 | 9.68 | +0.62% | 1,519,800 |
24-05-30 | 9.62 | -2.04% | 1,427,700 |
24-05-29 | 9.82 | +1.55% | 2,013,630 |
24-05-28 | 9.67 | -3.30% | 2,592,600 |
End-of-day quote Shenzhen S.E., June 02, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-32.78% | 235M | |
+15.37% | 41.97B | |
+22.56% | 22.34B | |
+14.89% | 15.25B | |
+16.53% | 14B | |
+49.78% | 12.06B | |
-10.77% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 002898 Stock